Jan 13, 2020 / 06:30PM GMT
Cory William Kasimov - JP Morgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good morning, everyone. My name is Cory Kasimov, I'm the senior large-cap biotech analyst at JPMorgan. And it's my pleasure to introduce Regeneron, one of my favorite presentations every week at this conference. We have another 2 for one special with both CEO, Len Schleifer; and CSO, George Yancopoulos. And please note that following the presentation there is a breakout across the hall in the [Borgia] rooms.
With that, I'll turn it over first to Len. Thank you.
Leonard S. Schleifer - Regeneron Pharmaceuticals, Inc. - Co-Founder, President, CEO & Executive Director
Thank you, Cory. I wish your favoritism would show up in your ratings. Anyways, no, it is good to be here.
Let's see. Our favorite slide. You take a look at this. This is on our website. There's a lot of things I might say here that I might regret and this should cover some of those sins.
It's fun to look back a decade ago, given that this is the beginning of the
Regeneron Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers